Clinical Trial Update: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation [NA]

View source ↗

Summary

A clinical trial evaluating transcutaneous auricular neuromodulation for Hypermobile Ehlers-Danlos syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ehlers-danlos Syndrome
• Hypermobile Ehlers-danlos Syndrome

Snippet

Sponsor: Medical University of South Carolina | Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder | NA | Status: COMPLETED